Skip to main content
. 2018 Aug 31;13(8):e0200433. doi: 10.1371/journal.pone.0200433

Fig 1. Growth of cancer cells inhibited by EgKI-1.

Fig 1

(a) CJM, MDA-MB-231 and HeLa cells lost shape and started dying when treated with 1 μM EgKI-1 (0.8 μg in 100 μl/ well) over time. (b) Dose-dependent growth inhibition curves with varying concentrations of EgKI-1.